Bank Of New York Mellon Corp Novo Nordisk A S Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $46.3 Million - $61 Million	451,078 New	451,078 $61 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $2.6 Million - $3.19 Million	-27,321 Reduced 5.34%	484,674 $48.3 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $2.24 Million - $2.65 Million	21,729 Added 4.43%	511,995 $57.1 Million
Q1 2022 May 11, 2022	BUY	$93.1 - $112.54 $4.46 Million - $5.39 Million	47,903 Added 10.83%	490,266 $54.4 Million
Q4 2021 Feb 11, 2022	BUY	$95.88 - $117.08 $2.85 Million - $3.48 Million	29,705 Added 7.2%	442,363 $49.5 Million
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $4 Million - $5.06 Million	47,412 Added 12.98%	412,658 $39.6 Million
Q2 2021 Aug 11, 2021	BUY	$67.66 - $84.76 $1.88 Million - $2.35 Million	27,770 Added 8.23%	365,246 $30.6 Million
Q1 2021 May 13, 2021	BUY	$67.06 - $75.82 $2.83 Million - $3.2 Million	42,150 Added 14.27%	337,476 $22.8 Million
Q4 2020 Feb 09, 2021	BUY	$63.89 - $73.8 $2.04 Million - $2.36 Million	31,995 Added 12.15%	295,326 $20.6 Million
Q3 2020 Nov 12, 2020	BUY	$63.69 - $70.22 $179,605 - $198,020	2,820 Added 1.08%	263,331 $18.3 Million
Q2 2020 Aug 12, 2020	SELL	$58.54 - $67.94 $46.6 Million - $54.1 Million	-796,457 Reduced 75.35%	260,511 $17.1 Million
Q1 2020 May 06, 2020	BUY	$49.46 - $64.78 $285,977 - $374,557	5,782 Added 0.55%	1,056,968 $63.6 Million
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $766,098 - $895,164	-15,365 Reduced 1.44%	1,051,186 $60.8 Million
Q3 2019 Nov 07, 2019	BUY	$47.54 - $53.43 $547,565 - $615,406	11,518 Added 1.09%	1,066,551 $55.1 Million
Q2 2019 Aug 12, 2019	SELL	$46.79 - $52.47 $458,963 - $514,678	-9,809 Reduced 0.92%	1,055,033 $53.8 Million
Q1 2019 May 14, 2019	SELL	$46.36 - $52.63 $329,016 - $373,515	-7,097 Reduced 0.66%	1,064,842 $55.7 Million
Q4 2018 Feb 11, 2019	SELL	$41.54 - $47.25 $2.44 Million - $2.78 Million	-58,850 Reduced 5.2%	1,071,939 $49.4 Million
Q3 2018 Nov 09, 2018	SELL	$46.76 - $51.24 $1.89 Million - $2.07 Million	-40,367 Reduced 3.45%	1,130,789 $0
Q2 2018 Aug 06, 2018	SELL	$44.29 - $50.42 $3.33 Million - $3.79 Million	-75,134 Reduced 6.03%	1,171,156 $54 Million
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $2.94 Million - $3.53 Million	-60,666 Reduced 4.64%	1,246,290 $61.4 Million
Q4 2017 Feb 09, 2018	BUY	$47.53 - $53.73 $62.1 Million - $70.2 Million	1,306,956	1,306,956 $70.1 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$1.76 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.26 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.25 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.16 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.07 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account